“Institutional Challenges for the Clinical Application of Regenerative Medicine”
date : 12/4/2006

Based on policy recommendations made by the Health Policy Institute, Japan, the challenges facing legislation for regenerative medicine were debated. The focus was on: ①evaluation/approval systems and ②cell bank issues.
The symposium began with a presentation of the key issues by Prof. Koji Kawakami (Kyoto University), who had directed our policyrecommendation. Then, participants engaged in debate after an explanation by Dr. Satoshi Toyoshima (Pharmaceuticals and Medical Devices Agency) on the status of evaluation and approval systems for regenerative medicine technology and a presentation by lawmaker Rep. Yutaka Fukushima (New Komeito), representing “Diet Members for the Promotion of the Use of Autologous Cells in Regenerative Medicine”. Researchers, companies, journalists and other opinion leaders from a variety of fields, as well as lawmakers and bureaucrats were invited to the debate. Our policy recommendations and images from the symposium were introduced and coveredby many newspapers and magazines.
The symposium began with a presentation of the key issues by Prof. Koji Kawakami (Kyoto University), who had directed our policyrecommendation. Then, participants engaged in debate after an explanation by Dr. Satoshi Toyoshima (Pharmaceuticals and Medical Devices Agency) on the status of evaluation and approval systems for regenerative medicine technology and a presentation by lawmaker Rep. Yutaka Fukushima (New Komeito), representing “Diet Members for the Promotion of the Use of Autologous Cells in Regenerative Medicine”. Researchers, companies, journalists and other opinion leaders from a variety of fields, as well as lawmakers and bureaucrats were invited to the debate. Our policy recommendations and images from the symposium were introduced and coveredby many newspapers and magazines.
Registration deadline: 2006-12-03
Exhibition date:2006-12-04
Top Research & Recommendations Posts
- [Policy Recommendations] Expectations for the 2023 UHC Political Declaration from a Planetary Health Perspective (September 8, 2023)
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] Signs Open Letter Calling for Action at UN High-Level Meeting on Pandemic Prevention, Preparedness and Response (September 12, 2023)
- [Activity Report] Recommendations for Creating a Sustainable Innovation Ecosystem for Antimicrobial R&D (August 1, 2023)
- [Policy Recommendations] Building a Research and Development System Together With People Living with Dementia and Their Families to Drive Parallel Progress in Creating an Inclusive Society and Advancing R&D (April 25, 2023)
- [Recommendations] Mental Health 2020 – Proposal for Tomorrow: Five Perspectives on Mental Health Policy (July 21, 2020)
- [Event Report] “Global Trends and Japan’s Mental Health Policy” Global Expert Meeting (December 18, 2019)
Featured Posts
-
2023-09-14
[Registration Open] An Online Seminar for World Mental Health Day 2023 – Mental Health for People in Their Teens and Twenties: Putting Our Heads Together to Think of Hints for Supporting Mental Health for Young People (October 4, 2023)
-
2023-09-15
[Urgent Recommendations] The Ideal System for Obstetric Care in Japan in the Era of Birthrate Decline (September 15, 2023)
-
2023-09-21
[Registration Open] (Webinar) The 120th HGPI Seminar – Necessary Steps for Promoting the Integrated Provision of Palliative Care from Post-diagnosis to End-of-Life With Addressing Cancer Related Pain (October 10, 2023)